Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine-A review

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Pharmacognosy Reviews

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Silybum marianum (milk thistle) and indinavir: an RCT and meta-analysis

  2010cited by this paper
• Effect of silybin and its glycosides on the expression of cytochromes P450 1A2 and 3A4 in primary cultures of human hepatocytes

  2005cited by this paper
• Silymarin treatment of viral hepatitis: a systematic review

  2005cited by this paper
• Silybin and silymarin--new effects and applications.

  2005cited by this paper
• Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases.

  2004cited by this paper
• Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.

  2004cited by this paper
• Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo-controlled clinical study.

  2002cited by this paper
• Antioxidant Flavonoids : Structure , Function and Clinical Usage

  2002cited by this paper
• Physiological responses to a natural antioxidant flavonoid mixture, silymarin, in BALB/c mice: II. alterations in thymic differentiation correlate with changes in c-myc gene expression.

  2002cited by this paper
• Milk thistle for the treatment of liver disease: a systematic review and meta-analysis.

  2002cited by this paper
• Treatment of Amatoxin Poisoning: 20-Year Retrospective Analysis

  2002cited by this paper
• Antioxidant properties of silybin glycosides

  2002cited by this paper
• Oxidative Stress, Plant-Derived Antioxidants and Liver Fibrosis

  2002cited by this paper
• SILYMARIN-A HEPATOPROTECTIVE AGENT

  2002cited by this paper
• Silymarin protects dopaminergic neurons against lipopolysaccharide‐induced neurotoxicity by inhibiting microglia activation

  2002cited by this paper
• Effect of Silybin and its congeners on human liver microsomal cytochrome P450 activities

  2002cited by this paper
• Which patients with hepatitis C develop liver complications?

  2000cited by this paper
• Effect of Withania somnifera glycowithanolides on iron‐induced hepatotoxicity in rats

  2000cited by this paper
• Hepatoprotective activity of a herbal protein CI‐1, purified from Cajanus indicus against β‐galactosamine HCl toxicity in isolated rat hepatocytes

  1999cited by this paper
• A review of plants used in the treatment of liver disease: part two.

  1999influential reference
• Hepatitis C: epidemiology and review of complementary/alternative medicine treatments.

  1999cited by this paper
• Herbal products for liver diseases: A therapeutic challenge for the new millennium

  1999influential reference
• Aminotransferase Levels and Silymarin in de novo Tacrine-Treated Patients with Alzheimer’s Disease

  1999cited by this paper
• An adverse reaction to the herbal medication milk thistle (Silybum marianum)

  1999cited by this paper
• DEVELOPMENT OF PHYTOMEDICINES FOR LIVER DISEASES

  1999cited by this paper
• Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.

  1998cited by this paper
• Milk Thistle (Silybum marianum) for the Therapy of Liver Disease

  1998cited by this paper
• Selective inhibition of NF‐κB activation by the flavonoid hepatoprotector silymarin in HepG2

  1998cited by this paper
• Protective and therapeutic effect of silymarin on the development of latent liver damage.

  1998cited by this paper
• Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients.

  1997cited by this paper
• Comparative effects of colchicine and silymarin on CCl4-chronic liver damage in rats.

  1997cited by this paper
• Effect of curcumin and eugenol on iron-induced hepatic toxicity in rats.

  1996cited by this paper
• [Silibinin and acute poisoning with Amanita phalloides].

  1996cited by this paper
• Inhibition of HBsAg secretion from Alexander cell line by Phyllanthus amarus.

  1996cited by this paper
• Dietary influences on membrane function : importance in protection against oxidative damage and disease

  1996cited by this paper
• Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin

  1996cited by this paper
• Effect of picroliv on liver regeneration in rats

  1996cited by this paper
• Hepatoprotective properties of Silybum marianum herbal preparation on ethanol-induced liver damage

  1996cited by this paper
• Hepatic disorders. Features and appropriate management.

  1995cited by this paper
• Effect of andrographolide against galactosamine-induced hepatotoxicity

  1995cited by this paper
• Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis

  1994cited by this paper
• Hepatoprotective mechanism of silymarin: no evidence for involvement of cytochrome P450 2E1.

  1994cited by this paper
• Effect of picroliv and silymarin on liver regeneration in rats

  1994cited by this paper
• Comparative pharmacokinetics of silipide and silymarin in rats

  1993cited by this paper
• Randomized open study of the dose-effect relationship of a short course of IdB 1016 in patients with viral or alcoholic hepatitis

  1993cited by this paper
• Protective effect of silymarin on rat liver injury induced by ischemia

  1993cited by this paper
• A pilot study on the liver protective effect of silybin-phosphatidylcholine complex (IdB1016) in chronic active hepatitis.

  1993cited by this paper
• Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients.

  1992cited by this paper
• Study on dose-linearity of the pharmacokinetics of silibinin diastereomers using a new stereospecific assay.

  1992cited by this paper
• Cytoprotection in the nineties: experience with ursodeoxycholic acid and silymarin in chronic liver disease.

  1992cited by this paper
• Choleretic Effect of Andrographolide in Rats and Guinea Pigs1

  1992cited by this paper
• Ethanol elimination in man under influence of hepatoprotective silibinin.

  1991cited by this paper
• Effects of two bioflavonoids on certain cellular immune reactions in vitro.

  1990cited by this paper
• Prevention by silymarin of membrane alterations in acute CCI4 liver damage

  1990cited by this paper
• Pharmacokinetic studies on IdB 1016, a silybin-phosphatidylcholine complex, in healthy human subjects

  1990cited by this paper
• Hepatoprotective activity of silymarin against hepatic damage in Mastomys natalensis infected with Plasmodium berghei.

  1989cited by this paper
• [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].

  1989cited by this paper
• Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver.

  1989cited by this paper
• Silybin Dihemisuccinate Protects Against Glutathione Depletion and Lipid Peroxidation Induced by Acetaminophen on Rat Liver

  1989cited by this paper
• [Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients].

  1989cited by this paper
• Characterization of a transporting system in rat hepatocytes. Studies with competitive and non-competitive inhibitors of phalloidin transport.

  1986cited by this paper
• Biochemical effects of the flavonolignane silibinin on RNA, protein and DNA synthesis in rat livers.

  1986cited by this paper
• Protection by silibinin against Amanita phalloides intoxication in beagles.

  1984cited by this paper
• Pharmacokinetic studies with silymarin in human serum and bile.

  1984cited by this paper
• Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind controlled study.

  1982cited by this paper
• Silybin inhibition of amatoxin uptake in the perfused rat liver.

  1980cited by this paper
• Liver protection by silymarin: in vitro effect on dissociated rat hepatocytes.

  1976cited by this paper
• The effects of silymarin on experimental phalloidine poisoning.

  1975cited by this paper
• [The chemistry and analysis of silymarin from Silybum marianum Gaertn].

  1974cited by this paper
• [Searching for a new therapeutic principle. Experience with hepatic therapeutic agent Legalon].

  1969cited by this paper
• DISEASES OF LIVER AND BILIARY SYSTEM

  1961influential reference

• Molecular pharmacology of inflammation: Medicinal plants as antiinflammatory agents

  2021cites this paper
• Silimarinin, ratlarda valproik asitin indüklediği karaciğer hasarı üzerine olumlu etkilerinin araştırılması

  2019cites this paper
• LIVER HISTOPATHOLOGY AT MICE WITH INDUCED DIABETES TREATED WITH VEGETAL EXTRACT OF SYLIBUM MARIANUM

  2018cites this paper
• Efficacy of Oral Supplementation with Silymarin and S-Adenosyl-L-Methioninein Patients with Non Alcoholic Fatty Liver Disease - A Pilot Study

  2016cites this paper
• Silymarin attenuated hepatic steatosis through regulation of lipid metabolism and oxidative stress in a mouse model of nonalcoholic fatty liver disease (NAFLD).

  2016cites this paper
• AIM 16-1318

  2016cites this paper
• Chapter 20 Progress towards the Discovery and Development of Specifically Targeted Inhibitors of Hepatitis C Virus

  2009cites this paper
• Modulation of inflammatory genes by natural dietary bioactive compounds.

  2009cites this paper